BENDAMUSTINE AS PART OF CONDITIONING REGIMEN FOR AUTOLOGOUS STEM‐CELL TRANSPLANTATION IN PATIENTS WITH AGGRESSIVE LYMPHOMAS: FINAL ANALYSIS OF A PHASE 2 STUDY FROM GELTAMO. (June 2017) - Martín, A.; Redondo, A.M.; Valcárcel, D.; González, A.P.; Suárez‐Lledó, M.; Bello, J.L.; Canales, M.; Gayoso, J.; Conde, E.; Jarque, I.; del Campo, R.; Arranz, R.; et al.